JSM 2012 Home

JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home

Activity Details

386 * ! Tue, 7/31/2012, 2:00 PM - 3:50 PM HQ-Sapphire B
Simulations to Aid Novel Clinical Trial Designs and Analyses — Topic Contributed Papers
Committee on Applied Statisticians , Biopharmaceutical Section , Section for Statistical Programmers and Analysts , International Indian Statistical Association
Organizer(s): Amarjot Kaur, Merck Research Laboratories
Chair(s): Amarjot Kaur, Merck Research Laboratories
2:05 PM Efficient Analyses of Phase II Dose-Range Trials to Optimize Phase III Trial Design Devan Mehrotra, Merck Research Laboratories ; Robin Mogg, Merck Research Laboratories ; Jianchang Lin, Millennium: The Takeda Oncology Company
2:25 PM Simulations in Forecasting Recruitment, Drug Supply, Event Occurrence, and Efficiency of Drug Development James Bolognese, Cytel Inc. ; Nitin Patel, Cytel Inc.
2:45 PM Using Simulation to Aid in the Development of a Phase II Bayesian Adaptive Design Elizabeth Krachey, GlaxoSmithKline ; Jennifer Gauvin, GlaxoSmithKline ; Theresa C. Ashton, GlaxoSmithKline ; Ohad Amit, GlaxoSmithKline
3:05 PM An Example of Simulation-Based Calculations of the Probability of Technical Success Neal Thomas, Pfizer Inc.
3:25 PM Floor Discussion

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.